Search

everythinglearnresearchcommunity

for

Search:↓

Microneedling improves skin conditions and self-esteem when tailored to individual needs and combined with other treatments.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

New research is helping develop better treatments for alopecia areata.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Using Lasswell's model can make CSR communication more effective and trusted.

Dermal macrophages might help regrow hair.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Different amounts of daylight affect cashmere growth in goats by changing the activity of certain genes and molecules.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Researchers found that certain RNA molecules might play a role in the growth of Cashmere goat hair.

Targeting Vδ1+T-cells may help treat alopecia areata.

The "Two-Cell Assemblage" assay is a new, simple method to identify substances that may promote hair growth.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

The document does not conclude the effectiveness of the 800-nm pulsed-diode laser for treating scalp cellulitis.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

JAK inhibitors show promise as a future treatment for hair loss.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.